Description
Afatin 40mg Tablet is a targeted therapy medication used in the treatment of certain types of non-small cell lung cancer (NSCLC) that have specific genetic mutations. The active ingredient in Afatin is Afatinib, a tyrosine kinase inhibitor (TKI). Afatinib works by blocking the activity of certain proteins called epidermal growth factor receptors (EGFRs) that are involved in the growth and spread of cancer cells. By inhibiting these receptors, Afatin helps to slow down or stop the growth of cancer cells and can lead to tumor shrinkage. It is typically prescribed for patients whose NSCLC tumors have tested positive for specific EGFR mutations, such as exon 19 deletions or L858R substitutions. The usual dosage is one 40mg tablet taken orally once daily, with or without food. However, dosage adjustments may be made by a healthcare professional based on individual response and tolerance. Common side effects can include diarrhea, rash, acneiform dermatitis, stomatitis, and nail changes. Serious side effects, though less common, can occur. It is crucial to discuss potential side effects with your doctor. Afatin 40mg Tablets should be stored at room temperature, away from moisture and heat, and kept out of reach of children.
